Fair enough I’ve been a happy holder over at least that time frame also. Like most NZ based Cos listed on the ASX, she seems to be a little ignored and/or undervalued compared to others.
I would live to see more value from the CDC investment reflected in the share price. I’ve been a very happy holder of MAQ over a similar time frame, and I know it’s not comparing apples with apples but over that time MAQ has been able to add quite a lot of share price growth primarily from establishing data centres that are about the size of a thimble compared to CDC…
Would love to see IFT re-rated in a similar way.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$10.02 |
Change
-0.055(0.55%) |
Mkt cap ! $9.777B | |||
| Open | High | Low | Value | Volume |
| $10.08 | $10.10 | $10.00 | $1.341M | 133.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 6310 | $10.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.02 | 387 | 2 |
View Market Depth
| Last trade - 13.55pm 18/06/2025 (20 minute delay) ? |
| IFT (ASX) Chart |